Cite
HARVARD Citation
O'Connor, O. et al. (n.d.). The addition of granulocyte-colony stimulating factor shifts the dose limiting toxicity and markedly increases the maximum tolerated dose and activity of the kinesin spindle protein inhibitor SB-743921 in patients with relapsed or refractory lymphoma: results of an international, multicenter phase I/II study. Leukemia & lymphoma. 56 (9), pp. 2585-2591. [Online].